Photofrin (porfimer sodium) is a medication used as a photosensitizer for photodynamic therapy for palliative treatment of obstructing endobronchial non-small cell lung cancer and palliative treatment of obstructing oesophageal cancer. (FDA approval Dec 1995)
In August 2003 the FDA approved its use for Barrett’s Esophagus [1].
Photofrin is a mixture of oligomers formed by ether and ester linkages of up to eight porphyrin units [2].
References
External links
- Photofrin at FDA
- Photofrin
- Photofrin marketing info
- Side effects of PDT with Photofrin
- History of Photofrin
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
